Standard InChI: InChI=1S/C27H27FN2O4/c28-18-25(31)23(16-20-10-4-1-5-11-20)29-26(32)24(17-21-12-6-2-7-13-21)30-27(33)34-19-22-14-8-3-9-15-22/h1-15,23-24H,16-19H2,(H,29,32)(H,30,33)/t23-,24-/m0/s1
1.Kang DH, Jun KY, Lee JP, Pak CS, Na Y, Kwon Y.. (2009) Identification of 3-acetyl-2-aminoquinolin-4-one as a novel, nonpeptidic scaffold for specific calpain inhibitory activity., 52 (9):[PMID:19419206][10.1021/jm8014734]
2.Kim SH, Lee E, Baek KH, Kwon HB, Woo H, Lee ES, Kwon Y, Na Y.. (2013) Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents., 23 (11):[PMID:23608763][10.1016/j.bmcl.2013.03.106]
3.Jeon KH,Lee E,Jun KY,Eom JE,Kwak SY,Na Y,Kwon Y. (2016) Neuroprotective effect of synthetic chalcone derivatives as competitive dual inhibitors against μ-calpain and cathepsin B through the downregulation of tau phosphorylation and insoluble Aβ peptide formation., 121 [PMID:27318120][10.1016/j.ejmech.2016.06.008]
4.Altıntop MD, Özdemir A, Temel HE, Demir Cevizlidere B, Sever B, Kaplancıklı ZA, Akalın Çiftçi G.. (2022) Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer., 244 [PMID:36270087][10.1016/j.ejmech.2022.114851]